Literature DB >> 5705936

Cardiac arrest.

H Windsor.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5705936     DOI： 10.5694/j.1326-5377.1968.tb83454.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  13 in total

Review 1.  Immunotherapy and predictive immunologic profile: the tip of the iceberg.

Authors:  Tatiana Cunha Pereira; Paulo Rodrigues-Santos; Jani Sofia Almeida; Fábio Rêgo Salgueiro; Ana Raquel Monteiro; Filipa Macedo; Rita Félix Soares; Isabel Domingues; Paula Jacinto; Gabriela Sousa
Journal:  Med Oncol       Date:  2021-03-31       Impact factor: 3.064

2.  Clinical perspectives for the use of total body PET/CT.

Authors:  Ronan Abgral; David Bourhis; Pierre-Yves Salaun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06       Impact factor: 9.236

3.  Machine learning for MRI radiomics: a study predicting tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma.

Authors:  Yun Bian; Yan Fang Liu; Hui Jiang; Yinghao Meng; Fang Liu; Kai Cao; Hao Zhang; Xu Fang; Jing Li; Jieyu Yu; Xiaochen Feng; Qi Li; Li Wang; Jianping Lu; Chengwei Shao
Journal:  Abdom Radiol (NY)       Date:  2021-06-29

Review 4.  Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.

Authors:  Nicolas A Giraldo; J David Peske; Catherine Sautès-Fridman; Wolf H Fridman
Journal:  Virchows Arch       Date:  2019-01-10       Impact factor: 4.064

5.  Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment.

Authors:  Xian-Ning Wu; Dan Su; Yi-De Mei; Mei-Qing Xu; Hao Zhang; Ze-Yu Wang; Li-Ling Li; Li Peng; Jun-Yi Jiang; Jia-Yi Yang; Dong-Jie Li; Hui Cao; Zhi-Wei Xia; Wen-Jing Zeng; Quan Cheng; Nan Zhang
Journal:  Cancer Immunol Immunother       Date:  2021-03-03       Impact factor: 6.968

6.  Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphoma.

Authors:  Akio Onishi; Shigeo Fuji; Shigehisa Kitano; Akiko Miyagi Maeshima; Kinuko Tajima; Junko Yamaguchi; Ichiro Kawashima; Akihisa Kawajiri; Tomonari Takemura; Ayumu Ito; Takashi Tanaka; Keiji Okinaka; Yoshihiro Inamoto; Saiko Kurosawa; Sung-Won Kim; Wataru Munakata; Dai Maruyama; Kensei Tobinai; Takahiro Fukuda
Journal:  Ann Hematol       Date:  2022-01-15       Impact factor: 3.673

Review 7.  Overcoming therapy resistance in EGFR-mutant lung cancer.

Authors:  Pasi A Jänne; Tony Mok; Solange Peters; Antonio Passaro
Journal:  Nat Cancer       Date:  2021-04-15

8.  Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.

Authors:  Hisao Imai; Ou Yamaguchi; Hiroyuki Minemura; Kensuke Suzuki; Satoshi Wasamoto; Yukihiro Umeda; Takashi Osaki; Norimitsu Kasahara; Junji Uchino; Tomohide Sugiyama; Shinichi Ishihara; Hisashi Ishii; Ichiro Naruse; Keita Mori; Mie Kotake; Kenya Kanazawa; Koichi Minato; Hiroshi Kagamu; Kyoichi Kaira
Journal:  Cancer Chemother Pharmacol       Date:  2020-03-19       Impact factor: 3.333

Review 9.  The emerging role of epigenetic therapeutics in immuno-oncology.

Authors:  Michael J Topper; Michelle Vaz; Kristen A Marrone; Julie R Brahmer; Stephen B Baylin
Journal:  Nat Rev Clin Oncol       Date:  2019-09-23       Impact factor: 66.675

Review 10.  Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.

Authors:  Michael J Grant; Roy S Herbst; Sarah B Goldberg
Journal:  Nat Rev Clin Oncol       Date:  2021-06-24       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.